LONG-TERM EFFECTIVENESS AND SAFETY OF LUSPATERCEPT FOR ANEMIA TREATMENT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES: A SYSTEMATIC REVIEW AND META-ANALYSIS

LONG-TERM EFFECTIVENESS AND SAFETY OF LUSPATERCEPT FOR ANEMIA TREATMENT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Introduction: Erythropoiesis-stimulating agents (ESA) are the primary treatment for anemia in most patients with low to moderate-risk myelodysplastic syndromes. However, in some patients, ESA therapy is not effective, and emerging evidence suggests that Luspatercept may offer longstanding benefits i...

Full description

Bibliographic Details
Main Authors: DVS Cavalcante, IQC Neto, IO Môro, RGO Galvão, JF Abreu, AM Cavalcante, MCFLC Freitas, V Lopes, BX Mendes, FD Xavier
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S253113792401085X

Internet

http://www.sciencedirect.com/science/article/pii/S253113792401085X

Similar Items